Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks rare blood disorder in pregnant women and babies

NCT ID NCT03755128

Completed Knowledge-focused Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 23 times

Summary

This study followed 17 pregnant women and their babies who were at high risk for a severe blood condition called hemolytic disease of the newborn. The goal was to learn more about how the disease progresses and what standard treatments are used. No new treatments were tested; instead, researchers observed outcomes like live births and the need for blood transfusions. The information gathered helps doctors better understand and manage this rare condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre Hospitalier Sainte Justine

    Montreal, Quebec, H3T 1C5, Canada

  • Columbia University Medical Center

    New York, New York, 10032, United States

  • Hosp Clinic de Barcelona

    Barcelona, 08028, Spain

  • Hosp. Univ. San Cecilio

    Granada, 18016, Spain

  • Justus-Liebig-Universität Gießen, Kinderherzzentrum

    Giessen, 35392, Germany

  • Karolinska Universitetssjukhuset Huddinge

    Stockholm, SE-141 86, Sweden

  • Leiden University Medical Center

    Leiden, 2333 ZA, Netherlands

  • Liverpool Hospital

    Liverpool, 2170, Australia

  • Mount Sinai Hospital

    Toronto, Ontario, M5G1X5, Canada

  • Oregon Health and Science University

    Portland, Oregon, 97239, United States

  • Queen Elizabeth Hospital

    Edgbaston, B15 2TG, United Kingdom

  • The Royal Women's Hospital

    Parkville, 3052, Australia

  • The University of British Columbia

    Vancouver, British Columbia, V6H 3N1, Canada

  • UPMC

    Pittsburgh, Pennsylvania, 15213, United States

  • Universitair Ziekenhuis Leuven

    Leuven, 3000, Belgium

  • University College London Hospitals NHSFT

    London, WC1E 6DB, United Kingdom

  • University of Cincinnati

    Cincinnati, Ohio, 45267, United States

  • University of Utah

    Salt Lake City, Utah, 84132, United States

Conditions

Explore the condition pages connected to this study.

EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN) ERYTHROBLASTOSIS, FETAL